Morphine produces potent antinociception, sedation, and hypothermia in humanized mice expressing human mu-opioid receptor splice variants. 2020

Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
Ph.D. Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan.

Morphine is a strong painkiller acting through mu-opioid receptor (MOR). Full-length 7-transmembrane (TM) variants of MOR share similar amino acid sequences of TM domains in rodents and humans; however, interspecies differences in N- and C-terminal amino acid sequences of MOR splice variants dramatically affect the downstream signaling. Thus, it is essential to develop a mouse model that expresses human MOR splice variants for opioid pharmacological studies. We generated 2 lines of fully humanized MOR mice (hMOR; mMOR mice), line #1 and #2. The novel murine model having human OPRM1 genes and human-specific variants was examined by reverse-transcription polymerase chain reaction and the MinION nanopore sequencing. The differences in the regional distribution of MOR between wild-type and humanized MOR mice brains were detected by RNAscope and radioligand binding assay. hMOR; mMOR mice were characterized in vivo using a tail-flick, charcoal meal, open field, tail suspension, naloxone precipitation tests, and rectal temperature measurement. The data indicated that wild-type and humanized MOR mice exhibited different pharmacology of morphine, including antinociception, tolerance, sedation, and withdrawal syndromes, suggesting the presence of species difference between mouse and human MORs. Therefore, hMOR; mMOR mice could serve as a novel mouse model for pharmacogenetic studies of opioids.

UI MeSH Term Description Entries
D007035 Hypothermia Lower than normal body temperature, especially in warm-blooded animals. Hypothermia, Accidental,Accidental Hypothermia,Accidental Hypothermias,Hypothermias,Hypothermias, Accidental
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
May 2016, Brain research bulletin,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
September 2014, Journal of neurochemistry,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
January 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
January 2000, European journal of pharmacology,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
February 2007, Behavioural brain research,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
August 2001, The Journal of biological chemistry,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
January 2002, AAPS pharmSci,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
November 2014, European journal of pharmacology,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
October 1998, Brain research. Molecular brain research,
Yi-Han Huang, and Yu-Wei Wu, and Jian-Ying Chuang, and Yung-Chiao Chang, and Hsiao-Fu Chang, and Pao-Luh Tao, and Horace H Loh, and Shiu-Hwa Yeh
January 1994, Life sciences,
Copied contents to your clipboard!